lundi 1 décembre 2008

Mesothelioma Research Provides New Insight on Treatment

"According to research from Milan, Italy, a study of pemetrexed plus cisplatin in patients with mesothelioma showed a significant survival benefit and higher response rate in comparison to regular cisplatin.
Mesothelioma is a rare form of cancer that most commonly develops as a result of asbestos exposure. The disease is especially noted for its extreme latency [...]"
(2008-12-1)
Read more...